The effects of beta-blocker use on cancer prognosis: a meta-analysis based on 319,006 patients

OncoTargets and Therapy
Zhijing NaDongyang Li

Abstract

Beta-blockers are antihypertensive drugs and have shown potential in cancer prognosis. However, this benefit has not been well defined due to inconsistent results from the published studies. To investigate the association between administration of beta-blocker and cancer prognosis, we performed a meta-analysis. A literature search of PubMed, Embase, Cochrane Library, and Web of Science was conducted to identify all relevant studies published up to September 1, 2017. Thirty-six studies involving 319,006 patients were included. Hazard ratios were pooled using a random-effects model. Subgroup analyses were conducted by stratifying ethnicity, duration of drug use, cancer stage, sample size, beta-blocker type, chronological order of drug use, and different types of cancers. Overall, there was no evidence to suggest an association between beta-blocker use and overall survival (HR=0.94, 95% CI: 0.87-1.03), all-cause mortality (HR=0.99, 95% CI: 0.94-1.05), disease-free survival (HR=0.59, 95% CI: 0.30-1.17), progression-free survival (HR=0.90, 95% CI: 0.79-1.02), and recurrence-free survival (HR=0.99, 95% CI: 0.76-1.28), as well. In contrast, beta-blocker use was significantly associated with better cancer-specific survival (CSS) (HR=0....Continue Reading

Citations

Apr 26, 2019·Toxicological Sciences : an Official Journal of the Society of Toxicology·Altaf MohammedMark Steven Miller
Jun 30, 2019·Cancers·Giulia GaspariniMassimo Falconi
Sep 19, 2019·Oncogene·Shu-Heng JiangZhi-Gang Zhang
Sep 5, 2019·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Vincenzo De GiorgiSilvia Benemei
Apr 8, 2019·Current Oncology Reports·Logan VincentRichard K Cheng
Feb 11, 2020·Frontiers in Cardiovascular Medicine·Anais AudebrandCanan G Nebigil
Apr 17, 2019·International Journal of Cancer. Journal International Du Cancer·Lucie LaplaneThomas Pradeu
Dec 28, 2019·Brain, Behavior, and Immunity·Annina SeilerChristopher P Fagundes
Dec 7, 2019·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Carlo FumagalliDiego Fornasari
Dec 4, 2020·Science Translational Medicine·Michela PeregoDmitry I Gabrilovich
Jan 21, 2021·Cancers·Simone L SchonkerenVeerle Melotte
Apr 22, 2020·The American Journal of Cardiology·Ohad OrenStephen L Kopecky
Jul 12, 2020·Journal of Neuroimmunology·Boris MravecLubica Horvathova
May 21, 2020·Journal of Cardiovascular Translational Research·Shreya PatelAna Barac
Jun 30, 2021·Annals of the New York Academy of Sciences·Francisco Stefânio BarretoDanielle S Macedo
Jul 24, 2021·Oncology Reports·Zi-Qian ZhangLing-Jia Qian
Aug 7, 2021·Immunology and Cell Biology·Nicole N Scheff, Jami L Saloman

❮ Previous
Next ❯

Software Mentioned

Stata
Engauge Digitizer

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.